Trademark: 97356365
Word
SOCIOMICS
Status
Pending
Status Code
730
Status Date
Monday, October 30, 2023
Serial Number
97356365
Mark Type
4000
Filing Date
Monday, April 11, 2022
Published for Opposition
Tuesday, March 21, 2023

Trademark Owner History
Phenomics Health Inc. - Owner At Publication

Classifications
42 Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, and the data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching; scientific and technological services in the field of pharmaceuticals featuring pharmacogenomic testing, analysis, and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of analyzing how an individual's cultural and environmental factors affect their response to drugs, and for the purposes of improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs switching; scientific and technological services, namely, scientific testing, evaluation, and analysis in the field of pharmaceuticals to determine a patient's medication and drug response associated with environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services, namely, scientific testing, evaluation, and analysis in the field of pharmaceuticals to determine a patient's medication and drug response associated with environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors, together with genetic variants, epigenetic factors and multiomics to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of supporting drug clinical trials and research into the field of new drug development and drug repurposing; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions, including stress resulting from adverse conditions, age-related health, isolation or cognitive circumstances, behavior harmful to self or others, childhood and adolescent neglect and abuse, adult trauma associated with events, including sexual, physical and psychological abuse, acute or chronic traumatic events, including military conflict, crimes, crashes, illnesses and family deaths, stress, trauma, abuse, poverty, food insecurity and hunger, imprisonment, interpersonal conflict, violence, presence or absence of parents, children, siblings, and other family members and acquaintances, gender, ancestry, transgenerational social factors, age, income, marital status, education level, language, other household data, cultural situations, circadian data, ethnicity-related health, community living conditions, biological sex, ethnicity, and other non-genetic factors; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation to determine a patient's medication and drug response associated with cultural and environmental factors, including stress resulting from adverse conditions, age-related health, isolation or cognitive circumstances, behavior harmful to self or others, childhood and adolescent neglect and abuse, adult trauma associated with events, including sexual, physical and psychological abuse, acute or chronic traumatic events, including military conflict, crimes, crashes, illnesses and family deaths, stress, trauma, abuse, poverty, food insecurity and hunger, imprisonment, interpersonal conflict, violence, presence or absence of parents, children, siblings, and other family members and acquaintances, gender, ancestry, transgenerational social factors, age, income, marital status, education level, language, other household data, cultural situations, circadian data, ethnicity-related health, community living conditions, biological sex, ethnicity, and other non-genetic factors; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's periodic changes in response to medical treatment, pharmacological adverse reactions, drug-drug interactions, drug dosing changes, and new or recurring comorbidities

Trademark Events
Nov 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 30, 2023
Sou Extension 1 Granted
Oct 30, 2023
Sou Extension 1 Filed
Oct 30, 2023
Sou Teas Extension Received
May 16, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 21, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 21, 2023
Published For Opposition
Mar 1, 2023
Notification Of Notice Of Publication E-Mailed
Feb 10, 2023
Approved For Pub - Principal Register
Jan 9, 2023
Teas/Email Correspondence Entered
Jan 9, 2023
Correspondence Received In Law Office
Jan 9, 2023
Teas Response To Office Action Received
Jul 11, 2022
Notification Of Non-Final Action E-Mailed
Jul 11, 2022
Non-Final Action E-Mailed
Jul 11, 2022
Non-Final Action Written
Jun 15, 2022
Assigned To Examiner
Apr 15, 2022
New Application Office Supplied Data Entered
Apr 14, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24